Vice President, Global Marketing

About this role

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

Vice President, Global Marketing

Reporting to the CCO, the Vice President, Global Marketing will lead the development and execution of the ex-U.S. commercial strategy. This individual will play a critical role in shaping global market strategy, ensuring alignment with U.S. commercial objectives, and optimizing long-term global revenue potential.

This role requires a highly strategic and analytical leader who can operate cross-functionally across commercial, clinical, regulatory, and business development to define market entry strategies, influence development programs, and secure partnerships across key international markets.

Key Responsibilities:

Global Commercial Strategy (Ex-U.S.)

• Lead global (ex-U.S.) market identification, prioritization, and segmentation across key geographies

• Develop and execute go-to-market strategies tailored by geography and indication

• Define optimal pathways to market entry, including indication prioritization

• Provide Commercial support to help inform lifecycle prioritization

Cross-Functional Leadership

• Partner closely with Clinical and Regulatory teams to shape development programs that align with commercial objectives and regulatory requirements

• Influence clinical study design and sequencing to maximize global commercial opportunity

• Ensure alignment across stakeholders to maintain a unified strategy

• Partner with Market Access to evaluate pricing and reimbursement dynamics across international markets, including health technology assessment (HTA) environments

• Identify and mitigate risks related to international reference pricing and Most Favored Nation (MFN) implications

Business Development & Partnerships

• Lead business development efforts to identify, evaluate, and secure…